Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Screening Program Performance - Second Edition

Table of Contents

• Acknowledgments
• Background
• Introduction
  • Organized Breast Cancer Screening in Canada
  • The Canadian Breast Cancer Screening Database
  • History of the Evaluation Indicators in Canada
  • Performance Measure Development
  • Data Sources and Collection
  • Application
  • Context of Performance Measures
• Program Performance Measures
  • Participation Rate
  • Retention Rate
  • Abnormal Call Rate
  • Invasive Cancer Detection Rate
  • In Situ Cancer Detection Rate
  • Diagnostic Interval
  • Positive Predictive Value
  • Benign to Malignant Open Surgical Biopsy Ratio
  • Benign Open Surgical Biopsy Rate
  • Benign to Malignant Core Biopsy Ratio
  • Benign Core Biopsy Rate
  • Invasive Cancer Tumour Size
  • Node Negative Rate in Cases of Invasive Cancer
  • Post-Screen Invasive Cancer Rate
• Future Directions
  • Monitoring Performance Measures
  • Performance Measures under Review
  • Proposed Performance Measures
• References
• Appendices
  • Appendix A: Conceptual Framework
  • Appendix B: Quality Determinants Working Group Members (QDWG)
  • Appendix C: Glossary

Our mission is to promote and protect the health of Canadians through leadership, partnership, innovation and action in public health.

     Public Health Agency of Canada

Ce document est aussi offert en français sous le titre : Rapport du Groupe de travail sur les indicateurs d’évaluation : Lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein

© Her Majesty the Queen in right of Canada, represented by the Minister of Health, 2007
Cat. N° HP35-5/2007E
ISBN 978-0-662-46165-4